Ravi Vij

2024

Mixed-Methods Study on the Responsiveness of the Comprehensive Score for Financial Toxicity Among People With Multiple Myeloma

Fiala, M. A., Leblanc, M. R., Coccia, K. W., Bandaru, S., Silberstein, A. E., Coles, T. & Vij, R., Jun 1 2024, In: JCO Oncology Practice. 20, 6, p. 835-842 8 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Plain language summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma

Rodriguez-Otero, P., Ailawadhi, S., Arnulf, B., Patel, K., Cavo, M., Nooka, A. K., Manier, S., Callander, N., Costa, L. J., Vij, R., Bahlis, N. J., Moreau, P., Solomon, S. R., Delforge, M., Berdeja, J., Truppel-Hartmann, A., Yang, Z., Favre-Kontula, L., Wu, F. & Piasecki, J. & 2 others, Cook, M. & Giralt, S., 2024, In: Future Oncology. 20, 18, p. 1221-1235 15 p.

Research output: Contribution to journal › Article › peer-review

Open Access

2023

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial

Slade, M., Fiala, M. A., Kirchmeyer, M., King, J., Gao, F., Schroeder, M. A., Stewart, A. K., Stockerl-Goldstein, K., Chen, C. & Vij, R., Dec 2023, In: Transplantation and Cellular Therapy. 29, 12, p. 764.e1-764.e7

Research output: Contribution to journal › Article › peer-review

Cross center single-cell RNA sequencing study of the immune microenvironment in rapid progressing multiple myeloma

Pilcher, W., Thomas, B. E., Bhasin, S. S., Jayasinghe, R. G., Yao, L., Gonzalez-Kozlova, E., Dasari, S., Kim-Schulze, S., Rahman, A., Patton, J., Fiala, M., Cheloni, G., Kourelis, T., Dhodapkar, M. V., Vij, R., Mehr, S., Hamilton, M., Cho, H. J., Auclair, D. & Avigan, D. E. & 4 others, Kumar, S. K., Gnjatic, S., Ding, L. & Bhasin, M., Dec 2023, In: npj Genomic Medicine. 8, 1, 3.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

D-dimer predicts venous thromboembolism in multiple myeloma: a nested case-control study

Sanfilippo, K. M., Fiala, M. A., Feinberg, D., Tathireddy, H., Girard, T., Vij, R., Di Paola, J. & Gage, B. F., Nov 2023, In: Research and Practice in Thrombosis and Haemostasis. 7, 8, 102235.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review

Gasoyan, H., Fiala, M. A., Doering, M., Vij, R., Halpern, M. & Colditz, G. A., Nov 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 11, p. e420-e427

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myeloma

Barnell, E. K., Skidmore, Z. L., Newcomer, K. F., Chavez, M., Campbell, K. M., Cotto, K. C., Spies, N. C., Ruzinova, M. B., Wang, T., Abro, B., Kreisel, F., Parikh, B. A., Duncavage, E. J., Frater, J. L., Lee, Y. S., Hassan, A., King, J. A., Kohnen, D. R., Fiala, M. A. & Welch, J. & 6 others, Uy, G. L., Vij, K., Vij, R., Griffith, M., Griffith, O. L. & Wartman, L. D., Jan 24 2023, In: Blood Advances. 7, 2, p. 236-245 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study

Mian, H., Wildes, T. M., Vij, R., Pianko, M. J., Major, A. & Fiala, M. A., Dec 2023, In: Blood cancer journal. 13, 1, 76.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

Epigenetic regulation during cancer transitions across 11 tumour types

Terekhanova, N. V., Karpova, A., Liang, W. W., Strzalkowski, A., Chen, S., Li, Y., Southard-Smith, A. N., Iglesia, M. D., Wendl, M. C., Jayasinghe, R. G., Liu, J., Song, Y., Cao, S., Houston, A., Liu, X., Wyczalkowski, M. A., Lu, R. J. H., Caravan, W., Shinkle, A. & Naser Al Deen, N. & 24 others, Herndon, J. M., Mudd, J., Ma, C., Sarkar, H., Sato, K., Ibrahim, O. M., Mo, C. K., Chasnoff, S. E., Porta-Pardo, E., Held, J. M., Pachynski, R., Schwarz, J. K., Gillanders, W. E., Kim, A. H., Vij, R., DiPersio, J. F., Puram, S. V., Chheda, M. G., Fuh, K. C., DeNardo, D. G., Fields, R. C., Chen, F., Raphael, B. J. & Ding, L., Nov 9 2023, In: Nature. 623, 7986, p. 432-441 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

19 Scopus citations

Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study

Slade, M., Fiala, M., Kelley, S., Crees, Z. D., Schroeder, M. A., Stockerl-Goldstein, K. & Vij, R., Apr 2023, In: Leukemia Research. 127, 107037.

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

First-in-Human Evaluation of Safety and Dosimetry of ⁶⁴Cu-LLP2A for PET Imaging

Laforest, R., Ghai, A., Fraum, T. J., Oyama, R., Frye, J., Kaemmerer, H., Gaehle, G., Voller, T., Mpoy, C., Rogers, B. E., Fiala, M., Shoghi, K. I., Achilefu, S., Rettig, M., Vij, R., DiPersio, J. F., Schwarz, S., Shokeen, M. & Dehdashti, F., Feb 1 2023, In: Journal of Nuclear Medicine. 64, 2

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.

Rodriguez-Otero, P., Ailawadhi, S., Arnulf, B., Patel, K., Cavo, M., Nooka, A. K., Manier, S., Callander, N., Costa, L. J., Vij, R., Bahlis, N. J., Moreau, P., Solomon, S. R., Delforge, M., Berdeja, J., Truppel-Hartmann, A., Yang, Z., Favre-Kontula, L., Wu, F. & Piasecki, J. & 2 others, Cook, M. & Giralt, S., 2023, In: New England Journal of Medicine. 388, 11, p. 1002-1014 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

230 Scopus citations

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

Crees, Z. D., Rettig, M. P., Jayasinghe, R. G., Stockerl-Goldstein, K., Larson, S. M., Arpad, I., Milone, G. A., Martino, M., Stiff, P., Sborov, D., Pereira, D., Micallef, I., Moreno-Jiménez, G., Mikala, G., Coronel, M. L. P., Holtick, U., Hiemenz, J., Qazilbash, M. H., Hardy, N. & Latif, T. & 12 others, García-Cadenas, I., Vainstein-Haras, A., Sorani, E., Gliko-Kabir, I., Goldstein, I., Ickowicz, D., Shemesh-Darvish, L., Kadosh, S., Gao, F., Schroeder, M. A., Vij, R. & DiPersio, J. F., Apr 2023, In: Nature medicine. 29, 4, p. 869-879 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

28 Scopus citations

Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

Wong, S., Hamidi, H., Costa, L. J., Bekri, S., Neparidze, N., Vij, R., Nielsen, T. G., Raval, A., Sareen, R., Wassner-Fritsch, E. & Cho, H. J., 2023, In: Frontiers in immunology. 14, 1085893.

Research output: Contribution to journal › Article › peer-review

Open Access

1 Scopus citations

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

Xu, Z., Choi, J., Cooper, M., King, J., Fiala, M. A., Liu, J., Pusic, I., Romee, R., Cashen, A., Jacoby, M. A., Stockerl-Goldstein, K., Abboud, C., Vij, R., Uy, G., Westervelt, P., Walter, M. J., DiPersio, J. F. & Schroeder, M. A., Nov 2023, In: Transplantation and Cellular Therapy. 29, 11, p. 699.e1-699.e9

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Yao, L., Wang, J. T., Jayasinghe, R. G., O’Neal, J., Tsai, C. F., Rettig, M. P., Song, Y., Liu, R., Zhao, Y., Ibrahim, O. M., Fiala, M. A., Fortier, J. M., Chen, S., Gehrs, L., Rodrigues, F. M., Wendl, M. C., Kohnen, D., Shinkle, A., Cao, S. & Foltz, S. M. & 12 others, Zhou, D. C., Storrs, E., Wyczalkowski, M. A., Mani, S., Goldsmith, S. R., Zhu, Y., Hamilton, M., Liu, T., Chen, F., Vij, R., Ding, L. & DiPersio, J. F., Apr 15 2023, In: Cancer research. 83, 8, p. 1214-1233 20 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

The Dynamics of Financial Toxicity in Multiple Myeloma

Fiala, M. A., Silberstein, A. E., Schroeder, M., Stockerl-Goldstein, K. & Vij, R., Apr 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 4, p. 266-272 7 p.

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

Mei, M., Pillai, R., Kim, S., Estrada-Merly, N., Afkhami, M., Yang, L., Meng, Z., Abid, M. B., Aljurf, M., Bacher, U., Beitinjaneh, A., Bredeson, C., Cahn, J. Y., Cerny, J., Copelan, E., Cutler, C., DeFilipp, Z., Perez, M. A. D., Farhadfar, N. & Freytes, C. O. & 26 others, Gadalla, S. M., Ganguly, S., Gale, R. P., Gergis, U., Grunwald, M. R., Hamilton, B. K., Hashmi, S., Hildebrandt, G. C., Lazarus, H. M., Litzow, M., Munker, R., Murthy, H. S., Nathan, S., Nishihori, T., Patel, S. S., Rizzieri, D., Seo, S., Shah, M. V., Solh, M., Verdonck, L. F., Vij, R., Sobecks, R. M., Oran, B., Scott, B. L., Saber, W. & Nakamura, R., Jan 2023, In: Haematologica. 108, 1, p. 150-160 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone

Loncharich, A. J., Fiala, M. A., Slade, M. J., Vickroy, A., Kavanaugh, M., Wilson, C., Schroeder, M. A., Stockerl-Goldstein, K., Vij, R. & Sanfilippo, K. M., Nov 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 11, p. 825-828 4 p.

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

2022

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

Hathi, D., Chanswangphuwana, C., Cho, N., Fontana, F., Maji, D., Ritchey, J., O’Neal, J., Ghai, A., Duncan, K., Akers, W. J., Fiala, M., Vij, R., DiPersio, J. F., Rettig, M. & Shokeen, M., Dec 2022, In: Scientific reports. 12, 1, 30.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma

D'souza, A., Shah, N., Rodriguez, C., Voorhees, P. M., Weisel, K., Bueno, O. F., Pothacamury, R. K., Freise, K. J., Yue, S., Ross, J. A., Polepally, A. R., Talati, C., Lee, S., Jin, Z., Buelow, B., Vij, R. & Kumar, S., Nov 1 2022, In: Journal of Clinical Oncology. 40, 31, p. 3576-3586 11 p.

Research output: Contribution to journal › Article › peer-review

64 Scopus citations

Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma

Costa, L. J., Lin, Y., Cornell, R. F., Martin, T., Chhabra, S., Usmani, S. Z., Jagannath, S., Callander, N. S., Berdeja, J. G., Kang, Y., Vij, R., Godby, K. N., Malek, E., Neppalli, A., Liedtke, M., Fiala, M., Tian, H., Valluri, S., Marino, J. & Jackson, C. C. & 5 others, Banerjee, A., Kansagra, A., Schecter, J. M., Kumar, S. & Hari, P., May 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 5, p. 326-335 10 p.

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Comprehensive Characterization of the Check for updates Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis

Yao, L., Jayasinghe, R. G., Lee, B. H., Bhasin, S. S., Pilcher, W., Doxie, D. B., Gonzalez-Kozlova, E., Dasari, S., Fiala, M. A., Pita-Juarez, Y., Strausbauch, M., Kelly, G., Thomas, B. E., Kumar, S. K., Cho, H. J., Anderson, E., Wendl, M., Dawson, T., D’souza, D. & Oh, S. T. & 17 others, Cheloni, G., Li, Y., DiPersio, J. F., Rahman, A. H., Dhodapkar, K. M., Kim-Schulze, S., Vij, R., Vlachos, I. S., Mehr, S., Hamilton, M., Auclair, D., Kourelis, T., Avigan, D., Dhodapkar, M. V., Gnjatic, S., Bhasin, M. K. & Ding, L., 2022, In: Cancer research communications. 2, 10, p. 1255-1265 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

O’Neal, J., Ritchey, J. K., Cooper, M. L., Niswonger, J., Sofía González, L., Street, E., Rettig, M. P., Gladney, S. W., Gehrs, L., Abboud, R., Prior, J. L., Haas, G. J., Jayasinghe, R. G., Ding, L., Ghobadi, A., Vij, R. & DiPersio, J. F., Jun 2022, In: Leukemia. 36, 6, p. 1625-1634 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma

Slade, M., Martin, T. G., Nathwani, N., Fiala, M. A., Rettig, M. P., Gao, F., Deol, A., Buadi, F. K., Kaufman, J. L., Hofmeister, C. C., Gregory, T. K., Berdeja, J., Chari, A., Rosko, A. & Vij, R., Dec 2022, In: Leukemia. 36, 12, p. 2917-2921 5 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related Mortality

Liu, L. W., Yn, A., Gao, F., Olson, M., Crain, M., Abboud, R., Westervelt, P., Abboud, C., Vij, R., Stockerl-Goldstein, K., Pusic, I., Cashen, A. F. & Schroeder, M. A., Aug 2022, In: Transplantation and Cellular Therapy. 28, 8, p. 510.e1-510.e9

Research output: Contribution to journal › Article › peer-review

Open Access

25 Scopus citations

LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

Mateos, M. V., Weisel, K., De Stefano, V., Goldschmidt, H., Delforge, M., Mohty, M., Cavo, M., Vij, R., Lindsey-Hill, J., Dytfeld, D., Angelucci, E., Perrot, A., Benjamin, R., van de Donk, N. W. C. J., Ocio, E. M., Scheid, C., Gay, F., Roeloffzen, W., Rodriguez-Otero, P. & Broijl, A. & 13 others, Potamianou, A., Sakabedoyan, C., Semerjian, M., Keim, S., Strulev, V., Schecter, J. M., Vogel, M., Wapenaar, R., Nesheiwat, T., San-Miguel, J., Sonneveld, P., Einsele, H. & Moreau, P., May 2022, In: Leukemia. 36, 5, p. 1371-1376 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

115 Scopus citations

POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

Jurczyszyn, A., Castillo, J. J., Olszewska-Szopa, M., Kumar, L., Thibaud, S., Richter, J., Flicker, K., Fiala, M., Vij, R., Yi, S., Xu, F., Silbermann, R., Gaisan, C. M., Ocio, E. M., Waszczuk-Gajda, A., Crusoe, E. D. Q., Salomon-Perzyński, A., Hus, I., Valls, J. D. & Gozzetti, A. & 6 others, Czepiel, J., Krzanowska, K., Chappell, A., Chellapuram, S. K., Suska, A. & Vesole, D. H., May 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 5, p. 297-304 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Recent Advances in the Treatment and Management of Relapsed/Refractory Multiple Myeloma: Expert Perspectives on the Role of New Therapies

Vij, R., 2022, In: Journal of Managed Care Medicine. 25, 1, p. 61-66 6 p.

Research output: Contribution to journal › Article › peer-review

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors

Guru Murthy, G. S., Kim, S., Hu, Z. H., Estrada-Merly, N., Abid, M. B., Aljurf, M., Bacher, U., Badawy, S. M., Beitinjaneh, A., Bredeson, C., Cahn, J. Y., Cerny, J., Diaz Perez, M. A., Farhadfar, N., Gale, R. P., Ganguly, S., Gergis, U., Hildebrandt, G. C., Grunwald, M. R. & Hashmi, S. & 28 others, Hossain, N. M., Kalaycio, M., Kamble, R. T., Kharfan-Dabaja, M. A., Hamilton, B. K., Lazarus, H. M., Liesveld, J., Litzow, M., Marks, D. I., Murthy, H. S., Nathan, S., Nazha, A., Nishihori, T., Patel, S. S., Pawarode, A., Rizzieri, D., Savani, B., Seo, S., Solh, M., Ustun, C., van der Poel, M., Verdonck, L. F., Vij, R., Wirk, B., Oran, B., Nakamura, R., Scott, B. & Saber, W., 2022, In: JAMA oncology. 8, 3, p. 404-411 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

45 Scopus citations

The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma

Multiple Myeloma Research Consortium, Dec 2022, In: Nature communications. 13, 1, 3750.

Research output: Contribution to journal › Article › peer-review

Open Access

32 Scopus citations

Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies

Bal, S., Malek, E., Kansagra, A., Usmani, S. Z., Vij, R., Godby, K. N., Cornell, R. F., Kang, Y., Umyarova, E., Giri, S., Chhabra, S., Liedtke, M., Callander, N. S., Hari, P., Kumar, S. & Costa, L. J., Mar 2022, In: Leukemia. 36, 3, p. 877-880 4 p.

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

2021

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Mikhael, J., Belhadj-Merzoug, K., Hulin, C., Vincent, L., Moreau, P., Gasparetto, C., Pour, L., Spicka, I., Vij, R., Zonder, J., Atanackovic, D., Gabrail, N., Martin, T. G., Perrot, A., Bensfia, S., Weng, Q., Brillac, C., Semiond, D., Macé, S. & Corzo, K. P. & 1 others, Leleu, X., May 2021, In: Blood cancer journal. 11, 5, 89.

Research output: Contribution to journal › Letter › peer-review

Open Access

54 Scopus citations

A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes

Huselton, E., Rettig, M. P., Fletcher, T., Ritchey, J., Gehrs, L., McFarland, K., Christ, S., Eades, W. C., Trinkaus, K., Romee, R., Kulkarni, S., Ghobadi, A., Abboud, C., Cashen, A. F., Stockerl-Goldstein, K., Uy, G. L., Vij, R., Westervelt, P., DiPersio, J. F. & Schroeder, M. A., 2021, In: Leukemia and Lymphoma. 62, 6, p. 1441-1449 9 p.

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

Alhallak, K., Jeske, A., de la Puente, P., Sun, J., Fiala, M., Azab, F., Muz, B., Sahin, I., Vij, R., DiPersio, J. F. & Azab, A. K., Dec 2021, In: Scientific reports. 11, 1, 19343.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myeloma

Liu, L., Fiala, M., Gao, F., King, J., Goldsmith, S., Wildes, T. M., Stockerl-Goldstein, K., Vij, R. & Schroeder, M. A., 2021, In: Leukemia and Lymphoma. 62, 12, p. 3043-3046 4 p.

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78

Fiala, M. A., King, J., Feinberg, D., Goldsmith, S. R., Schroeder, M. A., Ghobadi, A., Stockerl-Goldstein, K. E., Vij, R. & Wildes, T. M., Aug 2021, In: Bone Marrow Transplantation. 56, 8, p. 2016-2018 3 p.

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Co-evolution of tumor and immune cells during progression of multiple myeloma

Liu, R., Gao, Q., Foltz, S. M., Fowles, J. S., Yao, L., Wang, J. T., Cao, S., Sun, H., Wendl, M. C., Sethuraman, S., Weerasinghe, A., Rettig, M. P., Storrs, E. P., Yoon, C. J., Wyczalkowski, M. A., McMichael, J. F., Kohnen, D. R., King, J., Goldsmith, S. R. & O’Neal, J. & 9 others, Fulton, R. S., Fronick, C. C., Ley, T. J., Jayasinghe, R. G., Fiala, M. A., Oh, S. T., DiPersio, J. F., Vij, R. & Ding, L., Dec 1 2021, In: Nature communications. 12, 1, 2559.

Research output: Contribution to journal › Article › peer-review

Open Access

75 Scopus citations

Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis (Blood Cancer Journal, (2019), 9, 12, (97), 10.1038/s41408-019-0261-1)

Shah, N. N., Ahn, K. W., Litovich, C., Sureda, A., Kharfan-Dabaja, M. A., Awan, F. T., Ganguly, S., Gergis, U., Inwards, D., Karmali, R., Lazaryan, A., Lekakis, L., Munshi, P., Nathan, S., Saad, A. A., Solh, M., Steinberg, A., Vij, R., Wood, W. A. & Fenske, T. S. & 2 others, Smith, S. & Hamadani, M., Apr 2021, In: Blood cancer journal. 11, 4, 82.

Research output: Contribution to journal › Comment/debate

Open Access

Erratum: Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: A study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research (Haematologica (2020) 105:5 (1329-1338) DOI: 10.3324/haematol.2019.220756)

Acute Leukemia Committee of the CIBMTR, Aug 2021, In: Haematologica. 106, 8, p. 2295-2296 2 p.

Research output: Contribution to journal › Comment/debate

Open Access

4 Scopus citations

Evolving paradigms of therapy for multiple myeloma: State of the art and future directions

Goldsmith, S. R. & Vij, R., Jul 1 2021, In: JCO Oncology Practice. 17, 1, p. 415-418 4 p.

Research output: Contribution to journal › Comment/debate

Open Access

3 Scopus citations

Impact of a 40-gene targeted panel test on physician decision making for patients with acute myeloid leukemia

Barnell, E. K., Newcomer, K. F., Skidmore, Z. L., Krysiak, K., Anderson, S. R., Wartman, L. D., Oh, S. T., Welch, J. S., Stockerl-Goldstein, K. E., Vij, R., Cashen, A. F., Pusic, I., Westervelt, P., Abboud, C. N., Ghobadi, A., Uy, G. L., Schroeder, M. A., Dipersio, J. F., Politi, M. C. & Spencer, D. H. & 5 others, Duncavage, E. J., Ley, T. J., Griffith, M., Jacoby, M. A. & Griffith, O. L., Jan 2021, In: JCO Precision Oncology. 5, p. 191-203 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

Dimopoulos, M., Bringhen, S., Anttila, P., Capra, M., Cavo, M., Cole, C., Gasparetto, C., Hungria, V., Jenner, M., Vorobyev, V., Ruiz, E. Y., Yin, J. Y., Saleem, R., Hellet, M., Macé, S., Paiva, B. & Vij, R., Mar 4 2021, In: Blood. 137, 9, p. 1154-1165 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

49 Scopus citations

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

Alhallak, K., Sun, J., Wasden, K., Guenthner, N., O’Neal, J., Muz, B., King, J., Kohnen, D., Vij, R., Achilefu, S., DiPersio, J. F. & Azab, A. K., Aug 2021, In: Leukemia. 35, 8, p. 2346-2357 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

40 Scopus citations

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH

Cornell, R., Hari, P., Tang, S., Biran, N., Callander, N., Chari, A., Chhabra, S., Fiala, M. A., Gahvari, Z., Gandhi, U., Godby, K., Gupta, R., Jagannath, S., Jagosky, M., Kang, Y., Kansagra, A., Kauffman, M., Kodali, S., Kumar, S. K. & Lakshman, A. & 18 others, Liedtke, M., Lonial, S., Ma, X., Malek, E., Mansour, J., McGehee, E. F., Neppalli, A., Paul, B., Richardson, P., Scott, E. C., Shacham, S., Shah, J., Siegel, D. S., Umyarova, E., Usmani, S. Z., Varnado, W., Vij, R. & Costa, L., Jan 2021, In: American journal of hematology. 96, 1, p. E5-E8

Research output: Contribution to journal › Letter › peer-review

Open Access

20 Scopus citations

Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)

Walker, A. R., Marcucci, G., Yin, J., Blum, W., Stock, W., Kohlschmidt, J., Mrózek, K., Carroll, A. J., Eisfeld, A. K., Wang, E. S., Jacobson, S., Kolitz, J. E., Thakuri, M., Sutamtewagul, G., Vij, R., Stuart, R. K., Byrd, J. C., Bloomfield, C. D., Stone, R. M. & Larson, R. A., Jul 13 2021, In: Blood Advances. 5, 13, p. 2775-2787 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

18 Scopus citations

Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Tremblay, G., Daniele, P., Breeze, J., Li, L., Shah, J., Shacham, S., Kauffman, M., Engelhardt, M., Chari, A., Nooka, A., Vogl, D., Gavriatopoulou, M., Dimopoulos, M. A., Richardson, P., Biran, N., Siegel, D., Vlummens, P., Doyen, C., Facon, T. & Mohty, M. & 22 others, Meuleman, N., Levy, M., Costa, L., Hoffman, J. E., Delforge, M., Kaminetzky, D., Weisel, K., Raab, M., Dingli, D., Tuchman, S., Laurent, F., Vij, R., Schiller, G., Moreau, P., Richter, J., Schreder, M., Podar, K., Parker, T., Cornell, R. F., Lionel, K., Choquet, S. & Sundar, J., Dec 2021, In: BMC Cancer. 21, 1, 993.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”

Mian, H. S., Fiala, M. A., Sanchez, L., Vij, R. & Wildes, T. M., May 2021, In: Annals of Hematology. 100, 5, p. 1261-1266 6 p.

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

VLA4-Targeted nanoparticles hijack cell adhesion-mediated drug resistance to target refractory myeloma cells and prolong survival

Fontana, F., Scott, M. J., Allen, J. S., Yang, X., Cui, G., Pan, D., Yanaba, N., Fiala, M. A., O'Neal, J., Schmieder-Atteberry, A. H., Ritchey, J., Rettig, M., Simons, K., Fletcher, S., Vij, R., DiPersio, J. F. & Lanza, G. M., Apr 2021, In: Clinical Cancer Research. 27, 7, p. 1974-1986 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

17 Scopus citations

2020

A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

Mikhael, J., Richter, J., Vij, R., Cole, C., Zonder, J., Kaufman, J. L., Bensinger, W., Dimopoulos, M., Lendvai, N., Hari, P., Ocio, E. M., Gasparetto, C., Kumar, S., Oprea, C., Chiron, M., Brillac, C., Charpentier, E., San-Miguel, J. & Martin, T., Dec 2020, In: Leukemia. 34, 12, p. 3298-3309 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

38 Scopus citations

Ravi Vij

Research output

Search results